XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues from sales of products $ 66 $ 44
Cost of sales (14) (28)
Gross profit 52 16
Research and development expenses (20) (116)
Selling and marketing expenses (47) (57)
General and administrative expenses (604) (742)
Operating loss (619) (899)
Financing income (expenses), net (813) 5
Other expenses, net (12)
Changes in fair value of investments measured under the fair value option (Notes 3, 4,5,6), net 175 84
Net loss (1,257) (822)
Net - loss attributable to non-controlling interests 64 53
Net loss attributable to the Company’s stockholders’ equity $ (1,193) $ (769)
Loss per share (basic) $ (0.07) $ (0.26)
Weighted average number of shares of Common Stock outstanding- basic 16,170,201 2,960,667
Loss per share (diluted) $ (0.39) $ (0.26)
Weighted average number of shares of Common Stock outstanding - diluted 22,287,535 2,960,667
Comprehensive loss:    
Net loss $ (1,257) $ (822)
Other comprehensive income (loss) - Foreign currency translation adjustments (6)
Comprehensive loss (1,263) (822)
Other comprehensive income (loss) attributable to non-controlling interests -foreign currency translation adjustments 2
Comprehensive loss attributable to the Company’s stockholders $ (1,197) $ (769)